Balance Sheet
Cash Flow Statement
Daily Values
Growth Metrics
Income Statement
Consolidated Net IncomeDepreciation & Amortization - TotalEBITEBITDAEBTEPS (Basic)EPS (Weighted Average and Diluted)Gross ProfitIncome from Continuing OperationsIncome from Non-Controlling InterestsIncome towards Parent CompanyNet Income towards Common StockholdersNon Operating IncomeOperating ExpensesOperating IncomeOther Non Operating IncomeOther Operating ExpensesProfit After TaxRevenueSelling, General & AdministrativeShares Outstanding (Diluted Average)Shares Outstanding (Weighted Average)Tax ProvisionsTax Rate
Others
Ratios

P3 Health Partners (PIII) Other Operating Expenses (2021 - 2025)

P3 Health Partners (PIII) has disclosed Other Operating Expenses for 5 consecutive years, with $385.7 million as the latest value for Q1 2025.

  • For the quarter ending Q1 2025, Other Operating Expenses fell 4.62% year-over-year to $385.7 million, compared with a TTM value of $399.0 million through Sep 2025, down 65.67%, and an annual FY2024 reading of $13.3 million, changed N/A over the prior year.
  • Other Operating Expenses was $385.7 million for Q1 2025 at P3 Health Partners, up from $13.3 million in the prior quarter.
  • Across five years, Other Operating Expenses topped out at $1.1 billion in Q2 2022 and bottomed at -$17.7 million in Q2 2021.
  • Average Other Operating Expenses over 5 years is $319.0 million, with a median of $288.6 million recorded in 2023.
  • The sharpest move saw Other Operating Expenses soared 27322.23% in 2022, then plummeted 69.34% in 2023.
  • Year by year, Other Operating Expenses stood at $142.1 million in 2021, then surged by 430.74% to $754.4 million in 2022, then tumbled by 61.75% to $288.6 million in 2023, then plummeted by 95.4% to $13.3 million in 2024, then surged by 2806.88% to $385.7 million in 2025.
  • Business Quant data shows Other Operating Expenses for PIII at $385.7 million in Q1 2025, $13.3 million in Q4 2024, and $469.1 million in Q3 2024.